Clinical Trials
4
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (100.0%)Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria
Phase 2
- Conditions
- Oral Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
- Interventions
- Drug: Fosmidomycin-Piperaquine
- First Posted Date
- 2014-07-24
- Last Posted Date
- 2015-06-15
- Lead Sponsor
- Jomaa Pharma GmbH
- Target Recruit Count
- 100
- Registration Number
- NCT02198807
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children
- First Posted Date
- 2011-11-03
- Last Posted Date
- 2011-11-03
- Lead Sponsor
- Jomaa Pharma GmbH
- Target Recruit Count
- 52
- Registration Number
- NCT01464138
- Locations
- 🇲🇿
Centro de Investigacao em Saude da Manhica, Maputo, Mozambique
Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults
- First Posted Date
- 2011-11-03
- Last Posted Date
- 2011-11-03
- Lead Sponsor
- Jomaa Pharma GmbH
- Target Recruit Count
- 43
- Registration Number
- NCT01464125
- Locations
- 🇹🇭
Mahidol University, Bangkok, Thailand
Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate
- First Posted Date
- 2009-10-27
- Last Posted Date
- 2011-09-27
- Lead Sponsor
- Jomaa Pharma GmbH
- Target Recruit Count
- 40
- Registration Number
- NCT01002183
- Locations
- 🇹🇭
Mahidol University, Bangkok, Thailand
News
No news found